News - Sanofi

Filter

Current filters:

Sanofi

Popular Filters

101 to 125 of 302 results

Sanofi to produce avanafil for Vivus

02-08-2013

US drugmaker Vivus (Nasdaq: VVUS) says it has entered into a commercial supply agreement with French…

avanafilMen's HealthPharmaceuticalProductionSanofiSpedraVivus

FDA advisory committee backs approval of Sanofi drug for OTC

01-08-2013

The US Food and Drug Administration's Nonprescription Drugs Advisory Committee (NDAC) voted 10 to six,…

Nasacort AQNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySanofiTeva Pharmaceutical Industries

Sanofi sees end to "patent cliff" doldrums, as it misses forecasts

01-08-2013

French drug major Sanofi (Euronext: SAN) posted second-quarter 2013 financial results this morning (August…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

Takeda gains Chinese approval for diabetes drug

31-07-2013

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), says that the China Food and Drug Administration…

Asia-PacificDiabetesNesinaPharmaceuticalRegulationSanofiTakeda Pharmaceuticals

US and European Rxing decisions on metastatic colorectal cancer

15-07-2013

The effect of a therapy on overall survival and progression-free survival are attributes that most influence…

AvastinBayerEli LillyEuropeMarkets & MarketingNorth AmericaOncologyPharmaceuticalramucirumabRegeneronRocheSanofiStivargaZaltrap

Lilly and Boehringer Ingelheim's basal insulin MAA accepted by EMA

08-07-2013

US drug major Eli Lilly (NYSE: LLY) and family-owned German pharma firm Boehringer Ingelheim today (July…

Boehringer IngelheimDiabetesEli LillyLantusNovo NordiskPharmaceuticalSanofiVictoza

UK's NICE issues negative new draft guidance on Sanofi's Zaltrap

21-06-2013

The UK's drug watchdog the National Institute for Health Care and Excellence (NICE) has issued new draft…

EuropeOncologyPharmaceuticalPricingRegulationSanofiZaltrap

Curie-Cancer and Sanofi cooperate in research on ovarian cancer

19-06-2013

Carnot label, have established a three-year research collaboration to identify new therapeutic targets…

Curie-CancerOncologyPharmaceuticalResearchSanofi

Regulatory briefs: Sanofi's Fluzone; Roche' RoActemra; Takeda's Rienso

10-06-2013

French pharma major Sanofi (Euronext: SAN) today (June 10) announced that the US Food and Drug Administration…

Anti-Arthritics/RheumaticsBiotechnologyPharmaceuticalRegulationRocheSanofiTakeda PharmaceuticalsVaccines

Negative late-stage trial results for Sanofi's iniparib and otamixaban

03-06-2013

There was disappointing news from French drug major Sanofi (Euronext: SAN) this morning (June 3), as…

BiotechnologyCardio-vasculariniparibOncologyotamixabanPharmaceuticalResearchSanofi

Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations

22-05-2013

French drug major Sanofi (Euronext: SAN) and US biotech partner Regeneron Pharmaceuticals (Nasdaq: REGN)…

BiotechnologydupilumabPharmaceuticalRegeneronResearchRespiratory and PulmonarySanofi

Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results

17-05-2013

French drug major Sanofi (Euronext: SAN) and NYSE: SNY) this morning (May 17) revealed that the pivotal…

OncologyPharmaceuticalRegulationResearchSanofiSAR302503

Bayer initiates Ph III Stivarga study in liver cancer; Sanofi enrolls sarilumab patients

15-05-2013

German drug major Bayer (BAYN: DE) says that patient enrollment is underway for RESORCE (Regorafenib…

Anti-Arthritics/RheumaticsBayerOncologyPharmaceuticalRegeneronResearchSanofisarilumabStivarga

India's NPPA says drugmakers cannot raise prices of imported products

10-05-2013

At a meeting earlier this month, India's drug price regulator the National Pharmaceutical Pricing Authority…

AllerganAsia-PacificNovartisPharmaceuticalPricingSanofi

Six months post launch, US prescribing trends for Xtandi

07-05-2013

At six months following launch of Xtandi (Astellas Pharma/Medivation's enzalutamide), surveyed urologists…

3MAstellas PharmaJevtanaJohnson & JohnsonMarkets & MarketingMedivationNorth AmericaOncologyPharmaceuticalSanofiXtandiZytiga

Sanofi plans acceleration of expansion into Ukraine this year

07-05-2013

French drug major Sanofi (Euronext: SAN) is considering expanding its presence in Ukraine this year,…

Cardio-vascularDiabetesEuropeMarkets & MarketingPharmaceuticalProductionSanofi

101 to 125 of 302 results

Back to top